Clinical Factors Affecting Bevacizumab Efficacy With and Without Conventional Chemotherapy in Metastatic Colon Cancer.
Saved in:
| Title: | Clinical Factors Affecting Bevacizumab Efficacy With and Without Conventional Chemotherapy in Metastatic Colon Cancer. |
|---|---|
| Authors: | Islam R; Department of Hematology & Oncology, Ascension Medical Group, Steven Point, Medical college of Wisconsin, WI., Khan R; Division of Hematology & Oncology, University of Cincinnati College of Medicine, Cincinnati, OH., Ali A; Department of Internal Medicine, University of Iowa Hospitals and Clinics, Iowa City, IA., Kollu V; Division of Hematology & Oncology, Medical College of Wisconsin, Milwaukee, WI., Phan T; Office of Research Computing and Analytics, Marshfield Clinic Research Institute, Biomedical Informatics Research Center, Marshfield, WI., Chyou PH; Office of Research Computing and Analytics, Marshfield Clinic Research Institute, Biomedical Informatics Research Center, Marshfield, WI., Burmester JK; Department of Clinical Research, Gundersen Health System, La Crosse, WI; and., Kibriya MG; Department of Public Health Sciences, University of Chicago, Chicago, IL. |
| Source: | American journal of therapeutics [Am J Ther] 2020 Sep/Oct; Vol. 27 (5), pp. e500-e506. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 9441347 Publication Model: Print Cited Medium: Internet ISSN: 1536-3686 (Electronic) Linking ISSN: 10752765 NLM ISO Abbreviation: Am J Ther Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
